Lista de obras -

A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes

artículo científico publicado en 2020

Adjunctive Corticosteroid Treatment Against Yersinia pestis Improves Bacterial Clearance, Immunopathology, and Survival in the Mouse Model of Bubonic Plague

artículo científico publicado en 2016

Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague

artículo científico publicado en 2015

Correction: YopP-Expressing Variant of Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia

artículo científico publicado en 2014

Correction: Yopp-Expressing Variant ofY. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia.

artículo científico publicado en 2013

Disruption of the NlpD lipoprotein of the plague pathogen Yersinia pestis affects iron acquisition and the activity of the twin-arginine translocation system

artículo científico publicado en 2019

Early sensing of Yersinia pestis airway infection by bone marrow cells

artículo científico publicado en 2012

Host Iron Nutritional Immunity Induced by a Live Yersinia pestis Vaccine Strain Is Associated with Immediate Protection against Plague

artículo científico publicado en 2017

Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments

artículo científico publicado en 2020

Inhalational Gentamicin Treatment Is Effective Against Pneumonic Plague in a Mouse Model.

artículo científico publicado en 2018

Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague

artículo científico publicado en 2008

Phage Therapy Potentiates Second-Line Antibiotic Treatment against Pneumonic Plague

artículo científico publicado en 2022

Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody

artículo científico publicado en 2021

Postexposure Administration of a Yersinia pestis Live Vaccine for Potentiation of Second-Line Antibiotic Treatment Against Pneumonic Plague